Companies / Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc.

Nasdaq: VRCACIK 1660334WEST CHESTER, PA

Financials · FY2025

Revenue$35.58M
Net income$-17.89M
Total debt$0
Cash$11.20M
Diluted EPS$-1.68
Shares outstanding17.2M

Ownership

17.2M shares outstanding · as of Jul 31, 2026
2.6%10%+ / strategic
Ownership
10%+ / strategic2.56%439,657
Institutions28.42%4,882,245
Public float69.02%11,856,884

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
BKB Growth Investments, LLC10% owner
——
Prygocki Mark a SrDirector
——

Institutional holders 51

View all →
HolderValue% of shares
Armistice Capital, LLC$9.30M6.51%
Caligan Partners LP$7.68M5.38%
Affinity Asset Advisors, LLC$5.88M4.12%
Velan Capital Investment Management LP$3.92M2.75%
Cannell Capital LLC$3.62M3.99%
Stonepine Capital Management, LLC$2.94M2.06%
Boothbay Fund Management, LLC$2.33M1.63%
Kalehua Capital Management LLC$1.96M1.37%
Vanguard Group Inc$1.15M0.80%
Jane Street Group, LLC$845.3K0.59%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 5, 2026Prygocki Mark a Sr
Director
GrantStock Option (right to buy)—+16K
16,000
0.09% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Armistice Capital, LLCPassive13G/A—439,657—
Affinity Asset Advisors, LLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
VRCACommon StockEquity92511W207BBG00L03BYB7